Urgent Advocacy Needed: Extend 75/25 Blended Rate Relief

Published in Government Relations on February 22, 2024

As Senate and House leaders are continuing their efforts to secure funding beyond March 2024, the importance of the 75/25 blended-rate provision is becoming increasingly apparent. Under the current Continuing Resolution, the DMEPOS rates dropped on average 30% Jan. 1, 2024. There is a lot of work being done actively to get it included in an upcoming spending package, but we need your help!

We NEED every leader within our industry to personally contact healthcare staffers for your Senators and Representatives about S. 1294 and H.R. 5555. When you do, please request that they reach out in their respective leaders to support the inclusion of DMEPOS relief in non-rural areas within the next funding legislative package.

TAKE ACTION S. 1294               TAKE ACTION H.R. 5555

Extending the 75/25 blended rate not only benefits non-CBA, non-rural suppliers, but it also has broader implications:

  • Medicaid Rates: States that use Medicare rates as a guideline will benefit.
  • TRICARE and Private Payers: These rates influence other payers as well.

Furthermore, advocating for this relief reinforces the message to CMS that a long-term, market-based solution for Medicare ratemaking in the HME sector is crucial.

Even if you have already reached out to your legislator, we ask that you do so again! For an easy way to reach out to your legislator, please visit our action center.

Ike Isaacson's Update on the 75/25 Blended Rate

If you would like to learn more about this bill, please click here. While the key committees continue to work through bill priorities, we need your congressperson to stand up for you and for your clients to ensure that our bills are passed and that services can continue.

Let’s be Champions of Change to make sure that congressional leaders understand the urgency of this issue. Together, we can secure the relief our industry needs.

From Our Experts

Federal Actions This Week Signal The Administration Is Doubling Down On Its Goal To Eliminate Fraud Waste And Abuse thumbnail Federal Actions This Week Signal The Administration Is Doubling Down On Its Goal To Eliminate Fraud Waste And Abuse This week, the Trump administration, through the Centers for Medicare & Medicaid Services (CMS), announced a significant deferral of federal Medicaid matching funds to Minnesota alongside the release of a new Request for Information (RFI) tied to the administration's Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH) initiative. These actions along with the changes to DMEPOS accreditation and enrollment signal the administration's aggressive posture on Medicaid and Medicare... Trump Administration Announces Nationwide DMEPOS Enrollment Moratorium thumbnail Trump Administration Announces Nationwide DMEPOS Enrollment Moratorium In a press release published on the CMS website Feb. 25, 2026, it was announced that CMS will implement a six-month moratorium on new enrollments for DMEPOS suppliers. VGM Response To CMS Moratorium On New DMEPOS Provider thumbnail VGM Response To CMS Moratorium On New DMEPOS Provider The federal moratorium on new DME suppliers presents a defining moment for us as an industry—an opportunity to demonstrate that the VGM members serving patients are the gold standard. We have long shown that our members operate with integrity, excellence in compliance, and unmatched commitment to service, efficiency, and patient outcomes. Now, we must elevate that message. Proposed LCD Changes to Impact Seat Elevation on Group 2 Non-Complex Power Wheelchair Bases thumbnail Proposed LCD Changes to Impact Seat Elevation on Group 2 Non-Complex Power Wheelchair Bases The DME Medicare Administrative Contractors (MACs) issued a proposed Local Coverage Determination (LCD) change for seat elevation use on group 2 non-complex power wheelchair bases (K0830, K0831 and K0108 on group 2 non-complex HD bases). John Quinlan Named 2026 Van G. Miller Homecare Champion thumbnail John Quinlan Named 2026 Van G. Miller Homecare Champion AAHomecare announced earlier this week that John Quinlan of Quinlan's Pharmacy in New York has been selected as the recipient of this year's Van G. Miller Award. John has been a valued VGM member for many years, and his leadership within the DMEPOS community has made a meaningful impact on patients, providers, and the industry as a whole. His commitment to quality care, patient access, and industry advocacy consistently sets him apart. Legislative Update On DMEPOS Bills – Letter To CMS Admin Dr. Oz To Delay Competitive Bidding Program thumbnail Legislative Update On DMEPOS Bills – Letter To CMS Admin Dr. Oz To Delay Competitive Bidding Program Many of you have already contacted your legislators in support of key DME legislation, including the DMEPOS Relief Act, the Choices for Increased Mobility Act, and the Supplemental Oxygen Access Reform (SOAR) Act. We now have another important issue to bring to your attention. CMS Revises Nebulizer Policy and ABN Form thumbnail CMS Revises Nebulizer Policy and ABN Form CMS has issued an update regarding revisions to the CMS Nebulizer Policy Article and guidance on the Advanced Beneficiary Notice of Noncoverage (ABN) Form. For dates of service on or after Feb. 1, 2026, suppliers must include the KX, GA, or GZ modifier to claims for the following nebulizer items: CMS Releases Updated Telehealth FAQ After Funding Bill Extends Flexibilities Through 2027 thumbnail CMS Releases Updated Telehealth FAQ After Funding Bill Extends Flexibilities Through 2027 Earlier this week, Congress extended Medicare telehealth flexibilities through Dec, 31, 2027, as part of the newly signed federal funding bill. In response, CMS has released updated Telehealth Frequently Asked Questions (FAQ) to provide clarity on what the extension means for both patients and providers.